Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-24-030277
Filing Date
2024-12-31
Accepted
2024-12-31 13:20:10
Documents
1
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 form4a-12312024_011207.html 4/A  
1 form4a-12312024_011207.xml 4/A 4348
  Complete submission text file 0001415889-24-030277.txt   5892
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Issuer) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GENELUX CORPORATION 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address
Thomas John (Reporting) CIK: 0001939103 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41599 | Film No.: 241592204